TL;DR
This study reveals that individuals with lower household net worth (HHNW) are more likely to incur higher healthcare costs after radical cystectomy (RC) due to increased inpatient stays. Conversely, those with greater HHNW tend to utilize less costly outpatient and office visits, suggesting that financial flexibility significantly influences healthcare utilization patterns and overall costs.
What Problem Does This Paper Address?
Bladder cancer treatment, particularly radical cystectomy (RC), is associated with substantial financial burdens, potentially leading to "financial toxicity" or hardship for patients. While household income is often used as a proxy for socioeconomic status, it may not fully capture an individual's financial resources, especially for retired or elderly populations where assets and existing debt play a larger role. This gap in understanding how a more comprehensive measure of financial standing, like household net worth (HHNW), impacts healthcare utilization and costs after RC remains. The authors aim to investigate whether greater HHNW confers differential access to healthcare resources and ultimately influences healthcare costs in the crucial 90-day period following RC.
Methods
The researchers conducted a population-based cohort study using the OptumLabs® Data Warehouse (OLDW), a large de-identified database containing medical and pharmacy claims, laboratory results, and enrollment records for commercially insured individuals. They identified patients who underwent RC for bladder cancer between January 1, 2007, and April 10, 2021, ensuring continuous insurance coverage for at least six months before and after the index date (date of RC hospitalization).
Healthcare utilization was categorized into four mutually exclusive encounter types: acute inpatient, emergency department (ED), outpatient, and office visits. Costs were accrued from the index hospitalization to 90 days post-RC, encompassing both health plan costs (HPC) and out-of-pocket costs (OPC). Multivariable logistic regression models were employed to examine the association between HHNW and the odds of each encounter type, controlling for demographic factors such as age, race/ethnicity, gender, and education. HHNW was categorized into several brackets, and its association with encounter types was compared to a reference group (not reported HHNW).
Datasets
The primary dataset used in this study is the OptumLabs® Data Warehouse (OLDW). This de-identified database contains longitudinal health information on over 200 million enrollees, representing a significant portion of the US population, including commercially insured and Medicare Advantage enrollees. The dataset includes de-identified medical and pharmacy claims, laboratory results, and enrollment records. No new benchmarks were introduced; the study utilized existing real-world data.
Key Insights and Ideas
- HHNW as a Superior Proxy for Financial Flexibility: The study strongly suggests that HHNW is a more nuanced and comprehensive indicator of financial flexibility than household income alone. This is particularly relevant for understanding how individuals manage the significant costs associated with major medical procedures like RC.
- Financial Flexibility Drives Healthcare Utilization: The findings highlight a clear pattern where greater financial flexibility (higher HHNW) is associated with a shift towards less costly healthcare utilization (more office visits) and away from more expensive options (fewer acute inpatient or ED encounters).
- Disparities Persist Even in Commercially Insured Cohorts: Despite focusing on commercially insured individuals, the study identified disparities in healthcare utilization based on race/ethnicity and HHNW, underscoring that financial barriers and their impact on care access are not exclusive to publicly insured populations.
- Office Visits as a Cost-Saving Strategy: The study reinforces the idea that office visits are the least costly form of healthcare encounter, suggesting that promoting their utilization could be a key strategy for healthcare systems aiming to reduce overall costs.
Key Results
- Acute Inpatient Encounters: Lower HHNW was associated with increased odds of acute inpatient encounters, which incurred the highest health plan costs (HPC) and out-of-pocket costs (OPC). For instance, those with HHNW <$25,000 had an odds ratio (OR) of 0.89 for acute inpatient encounters compared to the reference group.
- ED Encounters: Similar to acute inpatient encounters, lower HHNW was linked to higher odds of ED visits. Those with HHNW <$25,000 had an OR of 0.96 for ED encounters.
- Office Visits: Higher HHNW was associated with greater odds of office visits, which had the lowest HPC. Individuals with HHNW >$500,000 had an OR of 1.25 for office visits.
- Race/Ethnicity Disparities: Black individuals had higher odds of acute inpatient (OR 1.22) and ED encounters (OR 1.20) compared to White counterparts. Asian and Hispanic patients had lower odds of outpatient encounters.
- Cost Breakdown: Acute inpatient encounters incurred the highest HPC (mean $24,642.80) and OPC (mean $1428.24). Office visits had the lowest HPC (mean $1126.78), while ED visits had the lowest OPC (mean $181.88).
Limitations and Future Work
The authors acknowledge several limitations:
- Data Granularity: The dataset lacked detailed information on tumor characteristics, staging, geographic location, complications, and specific healthcare plan benefits, which could provide a more comprehensive understanding of socioeconomic factors and their impact.
- HHNW Definition: The pre-assigned definition of HHNW, based on surname and street address, may not fully capture the complexity of "household" and net worth at the individual level, especially in cases of shared living arrangements with different surnames.
- Categorical Variables: HHNW and income were provided as categorical variables, limiting the ability to perform more granular numerical analyses.
- Quality of Care: The study could not directly measure the quality of care received, only associated costs.
- Over-ascertainment Risk: While efforts were made to link costs to encounters, there's a potential risk of over-ascertainment of cystectomy events.
- Generalizability: The findings may have limited generalizability to individuals outside the commercially insured cohort or those with different healthcare systems.
Future work could involve:
- Larger, More Diverse Cohorts: Exploring these associations in broader populations, including those with different insurance types and diverse geographic locations.
- More Granular Socioeconomic Measures: Incorporating more detailed assessments of financial resources, including assets, debts, and income at the individual level.
- Exploring Interactions: Investigating the complex interplay between race, geography, and healthcare access in greater detail.
- Quality of Care Metrics: Integrating measures of healthcare quality to understand how financial flexibility impacts both cost and outcomes.
Summary updated